Kuchyne na miru

Popular Articles

Apr 10, 2019
The significant scale that is necessary to break into the healthcare marketplace poses the greatest barrier to entry for women entrepreneurs. Shaleta Dunn outlines strategies that aspiring businesswomen can adopt to foster their success.
Apr 07, 2019
Pharmaceutical Executive
Sharon Callahan, this year’s Healthcare Businesswomen’s Association Woman of the Year, has built a career defined by an entrepreneurial drive to advance medical communications—and a commitment to breaking down barriers in the workplace.
Apr 06, 2019
Pharmaceutical Executive
Horizon Pharma's chief human resources officer, Irina Konstantinovsky, outlines her approach to recruiting and managing talent in an increasingly competitive marketplace.
Apr 05, 2019
Pharmaceutical Executive
Nine ways pharma companies can maximize a CDO’s potential value and impact on driving innovation as a business mandate.
Apr 05, 2019
Pharmaceutical Executive
Thinning talent pools, evolving industry trends and job-seeker motivations are testing traditional pharma hiring methods, where targeting new skills and capabilities must become the new norm.
Apr 01, 2019
Pharma needs to find new sources of revenue that also contribute to improved health outcomes. Outside of raising prices, new revenue can come from just three other sources, writes Tom Kottler.
Mar 14, 2019
Pharmaceutical Executive
By
Amicus Therapeutics CEO John Crowley discusses the growing role of the patient-centered view in company culture—not just in adding “deeper meaning” to drug development, but in building patient advocacy into everyday business practice and strategy.
Feb 10, 2019
Pharmaceutical Executive
By
How innovation growth has upped the pressure on China to compete globally, forcing upgrades in regulatory, quality, and standards.
Feb 09, 2019
Pharmaceutical Executive
By
How the nation’s rapidly changing regulatory climate is creating a new landscape for pharmaceutical service providers.
Feb 08, 2019
Pharmaceutical Executive
By
A profile of Dr. Xiaobin Wu, an accomplished leader in helming China operations at big pharmas, who believes his recent jump to biotech as GM of China and president of BeiGene will deliver his most lasting legacy.
native1_300x100
sledoc.com.ua

www.russ-love.com

краска хаммерайт купить
lorem ipsum